<DOC>
	<DOCNO>NCT02752737</DOCNO>
	<brief_summary>Cryo AF Global Registry prospective , global , multi-center , observational Post-Market Registry</brief_summary>
	<brief_title>Cryo AF Global Registry</brief_title>
	<detailed_description>The Cryo AF Global Registry prospective , global , multi-center , observational post-market registry ( PMR ) . The purpose study evaluate describe clinical performance safety data broad patient population treat commercially available Arctic Front™ Family Cardiac Cryoablation Catheters ( hereafter refer `` Arctic Front™ Cardiac Cryoablation Catheter System '' ) . The cryoballoon ablation ( CBA ) procedure perform accord routine hospital practice . The study expect 24 month enrollment period . The follow period intend align standard practice subject follow minimum 12 month post-procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subject ≥ 18 year age minimum age require local regulation Planned procedure use commercially available Arctic Front™ Cardiac Cryoablation Catheter Willing comply study requirement give inform consent ( define legally effective , documented confirmation subject 's voluntary agreement participate clinical study ) authorization per institution geographical requirement Subject enrol concurrent study approve concurrent enrollment global study manager Subject exclusion criterion require local law</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>